[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1988

Possible Association Between Breast Cancer and Malignant Melanoma

Author Affiliations

Departments of Dermatology and Social and Preventive Medicine; Department of Social and Preventive Medicine School of Medicine State University of New York at Buffalo 2211 Main St Buffalo, NY 14214

Arch Dermatol. 1988;124(7):1007. doi:10.1001/archderm.1988.01670070009002
Abstract

To the Editor.—  A letter was recently published suggesting an association between breast cancer and malignant melanoma.1 Hormonal factors were suggested by the authors as possibly having a role in explaining this observation. Based on the following studies, depressed pineal gland secretion of melatonin might hypothetically contribute to the development of both malignancies.Cohen et al2 first suggested the role of the pineal gland in the pathogenesis of breast cancer in 1978. It has been shown in experimental animals that decreased levels of melatonin result in increased levels of estrogen and prolactin.3 Receptors to estrogen and other hormones have been found on both breast cancer and melanoma cells.4,5 Pinealectomy in experimental animals results in increased growth of both dimethylbenz(a)anthracene-induced mammary tumors and transplanted melanomas,6,7 and replacement melatonin reverses these adverse effects.6,8 In addition, patients with estrogen-receptor-positive breast cancer and patients with melanoma have decreased

First Page Preview View Large
First page PDF preview
First page PDF preview
×